BioPortfolio - Quinone Reductases
No. 5 605 810 | quinone reductases | Structure function and mechanism of ... Selected MeSH subject headings created and maintained by the US NLM are used in
...
http://www.bioportfolio.com/indepth/Quinone_Reductases.html...
|
Patent Terms Extended Under 35 USC §156
4703752, LEA'S SHIELD, 23-Aug-05, 5 years, 23-Aug-10. Patent No. Tradename of Approved Product .... 4949718, THERMA CHOICE, 09-Sep-08, 605 days, 07-May-10 ...
http://www.uspto.gov/web/offices/pac/dapp/opla/term/156.html...
|
CLARINEX-D 24 HOUR 1 (desloratadine 5 mg and pseudoephedrine ...
NDA 21-605. 3 hours after dosing. No clinically meaningful changes were observed following ..... U.S. Patent Nos. 4659716; 4731447; 5595997; and 6100274 ...
http://www.fda.gov/Cder/foi/label/2005/021605lbl.pdf...
|
Extension Under 35 U.S.C. 156(e)(1) - OG Date: 29 July 2003
For example, U.S. Patent No. 4201772 was originally given a patent term extension of 468 ... date of the patent, as provided by 35 U.S.C. 156(d)(5)(E)(
ii). ...
http://www.uspto.gov/go/og/2003/week30/patxten.htm...
|
BioPortfolio - Nicotinamidase
FEBS J. 2008 Sep;275(18):4597-605. Epub 2008 Aug 11. ... US Patent No. Title. 7442523, Nucleic acid and amino acid sequences relating to Streptococcus ...
http://www.bioportfolio.com/indepth/Nicotinamidase.html...
|
Provisional Application - OG Date: 25 October 2005
See 5 U.S.C. 605(b). Executive Order 13132: This rule making does not contain .... the payment to: Director of the U.S. Patent and Trademark Office, ...
http://www.uspto.gov/go/og/2005/week43/patprov.htm...
|
DOCKETS ENTERED on 07/02/02
LET 605 HFS-810 to Colin Worldwide Corporation Vol#: 17 ... 01E-0363 Patent Term Extension Application, MIFEPREX No. 4386085 ...
http://www.fda.gov/ohrms/dockets/dailys/02/Jul02/070202/0702...
|
Federal Register /Vol. 67, No. 100/Thursday, May 23, 2002/Rules ...
(Regulatory Flexibility Act, 5 U.S.C.. 605(b)). .... by the U.S. Patent and Trademark Office. (USPTO) that was delivered by the ...
http://www.uspto.gov/web/offices/com/sol/notices/expmailrule...
|
Custom oligonucleotides
No right under any other patent claim (such as the patented 5’ Nuclease Process claims in US Patents. Nos. 5210015 and 5487972), no right to perform any ...
http://www.eurogentec.com/EGT/files/Oligonucleotides.pdf...
|
A Sec. No.
U. S. DEPARTMENT OF COMMERCE. Patent Office. Washington. MANUAL OF PATENT EXAMINING PROCEDURE. Instructions Regarding Revision No. 5 ...
http://www.uspto.gov/web/offices/pac/mpep/old/E3R7_Index.pdf...
|
